Revival Gold Drilling Program Now 25% Complete; Third Drill Rig Secured for Beartrack-Arnett
TORONTO, Sept. 14, 2020 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a […]
Verizon to speak at Goldman Sachs Communacopia Conference September 15
BASKING RIDGE, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) — Hans Vestberg, Chairman and CEO for Verizon, is scheduled to speak […]
Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease
Alzheimer’s Patients in Drug Groups Showed Statistically Significant Improvements in Biomarkers of Disease Compared to Placebo Group (P<0.05)Alzheimer’s Patients in […]
Consolidated Communications Announces Intention to Offer Senior Secured Notes
MATTOON, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) — Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (“Consolidated”) announced today that its wholly-owned […]
Evelo Biosciences Appoints Julie Carretero as Chief People Officer
CAMBRIDGE, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new […]
Leonovus Inc. Closes $395,000 Bridge Loan
OTTAWA, Sept. 14, 2020 (GLOBE NEWSWIRE) — Leonovus Inc., (“Leonovus” or the “Company”) (TSXV: LTV) further to its news release of […]
Flyht at Lake Street Best Ideas Growth Conference
CALGARY, Alberta, Sept. 14, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “Flyht”) […]
Keros Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
LEXINGTON, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]
89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH
All dose groups achieved statistically significant reductions in liver fat, with relative reductions of up to 60% versus baseline and […]
INmune Bio, Inc. to Participate in Oppenheimer’s Fall Healthcare Life Science & Med Tech Virtual Investor Summit, on September 23, 2020.
LA JOLLA, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company […]
